Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Aug 26, 2010 (rev. 1)


Kylin Therapeutics has appointed City of Hope researcher John Rossi to its scientific advisory board.

In addition to his position at the Beckman Research Institute of City of Hope, Rossi is an adjunct professor of biomedical sciences at the University of California, Riverside, and a co-founder of RNAi drug developer Dicerna Pharmaceuticals, where he also chairs the SAB.

He also serves on the SAB of Benitec.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.